newsEMA accepts submission for Zebinix use as a monotherapy for partial-onset seizures17 May 2016 | By Katie SadlerThe European Medicines Agency (EMA) has accepted Bial’s submission for once-daily epilepsy treatment Zebinix as monotherapy for partial-onset seizures.